drugset / Trial / NCT01544296
A Comparative Study of KHK6188
RandomizedCrossoverDouble-blindTreatment
Summary
This is a placebo-controlled, double blind, crossover study to evaluate the efficacy and safety of KHK6188 in postherpetic neuralgia when administered orally for 2 weeks.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KHK6188 | Unknown | — | Oral |